$ATRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Atara Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Atara Biotherapeutics, Inc.. Get notifications about new insider transactions in Atara Biotherapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | ATRA | Atara Biotherapeut ... | Yarema Kristin | Chief Commercial Of ... | Buy | P | 14.58 | 28,833 | 420,385 | 125,882 | 97 K to 125.9 K (+29.71 %) |
Jun 15 2021 | ATRA | Atara Biotherapeut ... | Yarema Kristin | Chief Commercial Of ... | Buy | P | 14.48 | 3,500 | 50,680 | 97,049 | 93.5 K to 97 K (+3.74 %) |
Jun 15 2021 | ATRA | Atara Biotherapeut ... | Yarema Kristin | Chief Commercial Of ... | Buy | P | 14.50 | 2,021 | 29,305 | 93,549 | 91.5 K to 93.5 K (+2.21 %) |
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Grant | A | 0.00 | 11,000 | 0 | 23,000 | 12 K to 23 K (+91.67 %) | |
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Grant | A | 0.00 | 11,000 | 0 | 23,000 | 12 K to 23 K (+91.67 %) | |
Jun 09 2021 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
Jun 09 2021 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Grant | A | 0.00 | 11,000 | 0 | 38,189 | 27.2 K to 38.2 K (+40.46 %) | |
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Renaud Ronald C JR | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Renaud Ronald C JR | Grant | A | 0.00 | 11,000 | 0 | 11,000 | 0 to 11 K | |
May 20 2021 | ATRA | Atara Biotherapeut ... | Murugan Amar | SVP, GC & Secretary | Sell | S | 14.55 | 5,681 | 82,659 | 91,744 | 97.4 K to 91.7 K (-5.83 %) |
May 20 2021 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 14.55 | 3,616 | 52,613 | 168,966 | 172.6 K to 169 K (-2.10 %) |
May 17 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 15.00 | 3,500 | 52,500 | 131,424 | 134.9 K to 131.4 K (-2.59 %) |
Apr 07 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 14.74 | 655 | 9,655 | 134,924 | 135.6 K to 134.9 K (-0.48 %) |
Mar 30 2021 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 14.58 | 1,761 | 25,675 | 172,582 | 174.3 K to 172.6 K (-1.01 %) |
Mar 30 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 14.58 | 2,640 | 38,491 | 135,579 | 138.2 K to 135.6 K (-1.91 %) |
Mar 15 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | M | 12.15 | 709 | 8,614 | 12,750 | |
Mar 15 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | M | 12.15 | 2,791 | 33,911 | 43,250 | |
Mar 15 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 17.41 | 7,000 | 121,870 | 138,219 | 145.2 K to 138.2 K (-4.82 %) |
Mar 15 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Buy | M | 12.15 | 3,500 | 42,525 | 145,219 | 141.7 K to 145.2 K (+2.47 %) |
Mar 04 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 16.74 | 1,665 | 27,872 | 141,719 | 143.4 K to 141.7 K (-1.16 %) |
Mar 04 2021 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 16.74 | 1,461 | 24,457 | 174,343 | 175.8 K to 174.3 K (-0.83 %) |
Mar 04 2021 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Sell | S | 16.74 | 4,887 | 81,808 | 367,621 | 372.5 K to 367.6 K (-1.31 %) |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Option Exercise | A | 17.11 | 81,327 | 1,391,098 | 81,327 | |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Grant | A | 0.00 | 53,879 | 0 | 100,129 | 46.3 K to 100.1 K (+116.50 %) |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Murugan Amar | SVP, GC & Secretary | Option Exercise | A | 17.11 | 63,028 | 1,078,094 | 63,028 | |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Murugan Amar | SVP, GC & Secretary | Grant | A | 0.00 | 41,756 | 0 | 97,425 | 55.7 K to 97.4 K (+75.01 %) |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | A | 17.11 | 56,929 | 973,771 | 56,929 | |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Grant | A | 0.00 | 37,715 | 0 | 143,384 | 105.7 K to 143.4 K (+35.69 %) |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Option Exercise | A | 17.11 | 68,314 | 1,168,511 | 68,314 | |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Grant | A | 0.00 | 45,258 | 0 | 175,804 | 130.5 K to 175.8 K (+34.67 %) |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Option Exercise | A | 17.11 | 176,886 | 3,025,635 | 176,886 | |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Grant | A | 0.00 | 117,187 | 0 | 372,508 | 255.3 K to 372.5 K (+45.90 %) |
Feb 09 2021 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 20.39 | 1,759 | 35,866 | 130,546 | 132.3 K to 130.5 K (-1.33 %) |
Feb 09 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 20.39 | 3,886 | 79,236 | 105,669 | 109.6 K to 105.7 K (-3.55 %) |
Jan 19 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | M | 12.15 | 354 | 4,301 | 13,459 | |
Jan 19 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | M | 12.15 | 3,146 | 38,224 | 46,041 | |
Jan 19 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 18.84 | 7,000 | 131,880 | 109,555 | 116.6 K to 109.6 K (-6.01 %) |
Jan 19 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Buy | M | 12.15 | 3,500 | 42,525 | 116,555 | 113.1 K to 116.6 K (+3.10 %) |
Dec 18 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | M | 12.15 | 354 | 4,301 | 13,813 | |
Dec 18 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | M | 12.15 | 3,146 | 38,224 | 49,187 | |
Dec 18 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 23.08 | 3,500 | 80,780 | 113,055 | 116.6 K to 113.1 K (-3.00 %) |
Dec 18 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 23.13 | 3,500 | 80,955 | 116,555 | 120.1 K to 116.6 K (-2.92 %) |
Dec 18 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Buy | M | 12.15 | 3,500 | 42,525 | 120,055 | 116.6 K to 120.1 K (+3.00 %) |
Nov 18 2020 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 19.77 | 1,469 | 29,048 | 132,061 | 133.5 K to 132.1 K (-1.10 %) |
Nov 18 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 19.77 | 1,648 | 32,588 | 116,555 | 118.2 K to 116.6 K (-1.39 %) |
Nov 18 2020 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Sell | S | 19.77 | 4,716 | 93,254 | 255,321 | 260 K to 255.3 K (-1.81 %) |
Nov 16 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | M | 12.15 | 667 | 8,104 | 16,333 | |
Nov 16 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | M | 12.15 | 2,833 | 34,421 | 50,167 | |
Nov 16 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 19.12 | 1,300 | 24,856 | 118,203 | 119.5 K to 118.2 K (-1.09 %) |
Nov 16 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 18.36 | 6,200 | 113,832 | 119,503 | 125.7 K to 119.5 K (-4.93 %) |
Nov 16 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Buy | M | 12.15 | 3,500 | 42,525 | 125,703 | 122.2 K to 125.7 K (+2.86 %) |
Aug 20 2020 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Sell | S | 12.09 | 4,807 | 58,117 | 260,037 | 264.8 K to 260 K (-1.82 %) |
Aug 20 2020 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 12.09 | 1,496 | 18,087 | 133,530 | 135 K to 133.5 K (-1.11 %) |
Aug 20 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 12.09 | 1,678 | 20,287 | 122,203 | 123.9 K to 122.2 K (-1.35 %) |
Jun 26 2020 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Sell | S | 12.92 | 12,135 | 156,784 | 264,844 | 277 K to 264.8 K (-4.38 %) |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Option Exercise | A | 10.54 | 24,500 | 258,230 | 24,500 | |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Option Exercise | A | 10.54 | 24,500 | 258,230 | 24,500 | |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Grant | A | 0.00 | 8,000 | 0 | 27,189 | 19.2 K to 27.2 K (+41.69 %) |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Grant | A | 0.00 | 8,000 | 0 | 27,189 | 19.2 K to 27.2 K (+41.69 %) |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | HEIDEN WILLIAM K | Director | Option Exercise | A | 10.54 | 24,500 | 258,230 | 24,500 | |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | HEIDEN WILLIAM K | Director | Grant | A | 0.00 | 8,000 | 0 | 20,500 | 12.5 K to 20.5 K (+64.00 %) |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | A | 10.54 | 24,500 | 258,230 | 24,500 | |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Grant | A | 0.00 | 8,000 | 0 | 100,818 | 92.8 K to 100.8 K (+8.62 %) |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Option Exercise | A | 10.54 | 24,500 | 258,230 | 24,500 | |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Grant | A | 0.00 | 8,000 | 0 | 33,854 | 25.9 K to 33.9 K (+30.94 %) |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Option Exercise | A | 10.54 | 24,500 | 258,230 | 24,500 | |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Grant | A | 0.00 | 8,000 | 0 | 28,000 | 20 K to 28 K (+40.00 %) |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Director | Option Exercise | A | 10.54 | 24,500 | 258,230 | 24,500 | |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Director | Grant | A | 0.00 | 8,000 | 0 | 12,000 | 4 K to 12 K (+200.00 %) |
Jun 10 2020 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 10.18 | 3,924 | 39,946 | 135,026 | 139 K to 135 K (-2.82 %) |
May 20 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 11.22 | 1,603 | 17,986 | 123,881 | 125.5 K to 123.9 K (-1.28 %) |
May 20 2020 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 11.22 | 1,428 | 16,022 | 137,375 | 138.8 K to 137.4 K (-1.03 %) |
May 20 2020 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Sell | S | 11.22 | 3,195 | 35,848 | 276,979 | 280.2 K to 277 K (-1.14 %) |
May 19 2020 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Option Exercise | A | 9.58 | 277,500 | 2,658,450 | 277,500 | |
May 19 2020 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Grant | A | 0.00 | 46,250 | 0 | 46,250 | 0 to 46.3 K |
May 12 2020 | ATRA | Atara Biotherapeut ... | Roncarolo Maria Grazia | Director | Option Exercise | A | 10.25 | 59,500 | 609,875 | 59,500 | |
Apr 30 2020 | ATRA | Atara Biotherapeut ... | Renaud Ronald C JR | Director | Option Exercise | A | 8.53 | 71,500 | 609,895 | 71,500 | |
Apr 21 2020 | ATRA | Atara Biotherapeut ... | Murugan Amar | SVP, GC & Secretary | Option Exercise | A | 8.20 | 110,000 | 902,000 | 110,000 | |
Apr 21 2020 | ATRA | Atara Biotherapeut ... | Murugan Amar | SVP, GC & Secretary | Grant | A | 0.00 | 55,000 | 0 | 55,000 | 0 to 55 K |
Apr 07 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 7.94 | 657 | 5,217 | 125,484 | 126.1 K to 125.5 K (-0.52 %) |
Mar 30 2020 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 9.17 | 1,827 | 16,754 | 137,330 | 139.2 K to 137.3 K (-1.31 %) |
Mar 30 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 9.17 | 2,740 | 25,126 | 126,141 | 128.9 K to 126.1 K (-2.13 %) |
Mar 03 2020 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Option Exercise | A | 12.15 | 73,750 | 896,063 | 73,750 | |
Mar 03 2020 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Grant | A | 0.00 | 66,875 | 0 | 139,157 | 72.3 K to 139.2 K (+92.52 %) |
Feb 19 2020 | ATRA | Atara Biotherapeut ... | Yarema Kristin | Chief Commercial Of ... | Option Exercise | A | 14.56 | 110,000 | 1,601,600 | 110,000 | |
Feb 10 2020 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 14.21 | 4,117 | 58,503 | 53,881 | 58 K to 53.9 K (-7.10 %) |
Feb 10 2020 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 14.21 | 1,781 | 25,308 | 72,282 | 74.1 K to 72.3 K (-2.40 %) |
Jan 28 2020 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Payment of Exercise | F | 13.62 | 9,900 | 134,838 | 130,174 | 140.1 K to 130.2 K (-7.07 %) |
Sep 30 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 13.51 | 3,500 | 47,285 | 57,998 | 61.5 K to 58 K (-5.69 %) |
Jul 01 2019 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Option Exercise | A | 20.25 | 13,000 | 263,250 | 13,000 | |
Jul 01 2019 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Grant | A | 0.00 | 4,000 | 0 | 19,189 | 15.2 K to 19.2 K (+26.33 %) |
Jul 01 2019 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Option Exercise | A | 20.25 | 13,000 | 263,250 | 13,000 | |
Jul 01 2019 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Grant | A | 0.00 | 4,000 | 0 | 20,000 | 16 K to 20 K (+25.00 %) |
Jul 01 2019 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Buy | P | 19.50 | 2,000 | 39,000 | 16,000 | 14 K to 16 K (+14.29 %) |
Jul 01 2019 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | A | 20.25 | 13,000 | 263,250 | 13,000 | |
Jul 01 2019 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Grant | A | 0.00 | 4,000 | 0 | 92,818 | 88.8 K to 92.8 K (+4.50 %) |
Jul 01 2019 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Option Exercise | A | 20.25 | 13,000 | 263,250 | 13,000 | |
Jul 01 2019 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Grant | A | 0.00 | 4,000 | 0 | 25,854 | 21.9 K to 25.9 K (+18.30 %) |
Jul 01 2019 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Director | Option Exercise | A | 20.25 | 13,000 | 263,250 | 13,000 | |
Jul 01 2019 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Director | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
Jun 25 2019 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Option Exercise | A | 20.43 | 225,000 | 4,596,750 | 225,000 | |
Jun 25 2019 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Grant | A | 0.00 | 140,074 | 0 | 140,074 | 0 to 140.1 K |
May 31 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 23.70 | 1,500 | 35,550 | 290,687 | 292.2 K to 290.7 K (-0.51 %) |
May 31 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 22.72 | 1,425 | 32,376 | 292,187 | 293.6 K to 292.2 K (-0.49 %) |
May 31 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 23.30 | 725 | 16,893 | 293,612 | 294.3 K to 293.6 K (-0.25 %) |
May 31 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 22.85 | 2,200 | 50,270 | 294,337 | 296.5 K to 294.3 K (-0.74 %) |
May 15 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 24.92 | 3,900 | 97,188 | 296,537 | 300.4 K to 296.5 K (-1.30 %) |
May 15 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 24.95 | 400 | 9,980 | 300,437 | 300.8 K to 300.4 K (-0.13 %) |
May 15 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 24.23 | 3,500 | 84,805 | 300,837 | 304.3 K to 300.8 K (-1.15 %) |
May 08 2019 | ATRA | Atara Biotherapeut ... | Berger Dietmar | Global Head of R&D | Payment of Exercise | F | 33.46 | 4,322 | 144,614 | 85,678 | 90 K to 85.7 K (-4.80 %) |
May 07 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | M | 20.40 | 1,500 | 30,600 | 65,000 | |
May 07 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 35.00 | 1,500 | 52,500 | 61,498 | 63 K to 61.5 K (-2.38 %) |
May 07 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Buy | M | 20.40 | 1,500 | 30,600 | 62,998 | 61.5 K to 63 K (+2.44 %) |
Apr 29 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.47 | 3,900 | 130,533 | 304,337 | 308.2 K to 304.3 K (-1.27 %) |
Apr 29 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.99 | 300 | 10,197 | 308,237 | 308.5 K to 308.2 K (-0.10 %) |
Apr 29 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.57 | 3,600 | 120,852 | 308,537 | 312.1 K to 308.5 K (-1.15 %) |
Apr 12 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.27 | 3,900 | 141,453 | 312,137 | 316 K to 312.1 K (-1.23 %) |
Apr 12 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.04 | 3,900 | 144,456 | 316,037 | 319.9 K to 316 K (-1.22 %) |
Apr 10 2019 | ATRA | Atara Biotherapeut ... | Kim Mina | Senior VP & General ... | Payment of Exercise | F | 36.85 | 3,674 | 135,387 | 66,389 | 70.1 K to 66.4 K (-5.24 %) |
Apr 03 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | M | 20.40 | 1,500 | 30,600 | 66,500 | |
Apr 03 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Payment of Exercise | F | 41.04 | 648 | 26,594 | 61,498 | 62.1 K to 61.5 K (-1.04 %) |
Apr 03 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 39.96 | 1,500 | 59,940 | 62,146 | 63.6 K to 62.1 K (-2.36 %) |
Apr 03 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Buy | M | 20.40 | 1,500 | 30,600 | 63,646 | 62.1 K to 63.6 K (+2.41 %) |
Mar 27 2019 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 74,063 | 64.1 K to 74.1 K (+15.61 %) |
Mar 27 2019 | ATRA | Atara Biotherapeut ... | Kim Mina | Senior VP & General ... | Grant | A | 0.00 | 10,000 | 0 | 70,063 | 60.1 K to 70.1 K (+16.65 %) |
Mar 27 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Grant | A | 0.00 | 15,000 | 0 | 62,146 | 47.1 K to 62.1 K (+31.82 %) |
Mar 27 2019 | ATRA | Atara Biotherapeut ... | Berger Dietmar | Global Head of R&D | Grant | A | 0.00 | 15,000 | 0 | 90,000 | 75 K to 90 K (+20.00 %) |
Mar 27 2019 | ATRA | Atara Biotherapeut ... | Porter Derrell | SVP, Head of Global ... | Grant | A | 0.00 | 10,000 | 0 | 31,688 | 21.7 K to 31.7 K (+46.11 %) |
Mar 19 2019 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Sell | S | 38.25 | 20,000 | 765,000 | 888,355 | 908.4 K to 888.4 K (-2.20 %) |
Mar 18 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.73 | 3,900 | 151,047 | 327,737 | 331.6 K to 327.7 K (-1.18 %) |
Mar 18 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.48 | 3,200 | 129,536 | 331,637 | 334.8 K to 331.6 K (-0.96 %) |
Mar 18 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.10 | 700 | 27,370 | 334,837 | 335.5 K to 334.8 K (-0.21 %) |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.13 | 3,900 | 140,907 | 335,537 | 339.4 K to 335.5 K (-1.15 %) |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.20 | 3,700 | 133,940 | 339,437 | 343.1 K to 339.4 K (-1.08 %) |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.22 | 200 | 7,044 | 343,137 | 343.3 K to 343.1 K (-0.06 %) |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Option Exercise | M | 13.20 | 21,500 | 283,800 | 0 | |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Option Exercise | M | 15.08 | 5,500 | 82,940 | 0 | |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Option Exercise | M | 24.05 | 10,500 | 252,525 | 0 | |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Option Exercise | M | 25.15 | 25,000 | 628,750 | 0 | |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Sell | S | 36.07 | 62,590 | 2,257,621 | 7,500 | 70.1 K to 7.5 K (-89.30 %) |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Buy | M | 13.20 | 21,500 | 283,800 | 70,090 | 48.6 K to 70.1 K (+44.25 %) |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Buy | M | 15.08 | 5,500 | 82,940 | 48,590 | 43.1 K to 48.6 K (+12.76 %) |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Buy | M | 24.05 | 10,500 | 252,525 | 43,090 | 32.6 K to 43.1 K (+32.22 %) |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Buy | M | 25.15 | 25,000 | 628,750 | 32,590 | 7.6 K to 32.6 K (+329.38 %) |
Feb 19 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Payment of Exercise | F | 40.45 | 1,176 | 47,569 | 332,243 | 333.4 K to 332.2 K (-0.35 %) |
Feb 19 2019 | ATRA | Atara Biotherapeut ... | Porter Derrell | SVP, Head of Global ... | Option Exercise | M | 14.30 | 4,000 | 57,200 | 109,666 | |
Feb 19 2019 | ATRA | Atara Biotherapeut ... | Porter Derrell | SVP, Head of Global ... | Sell | S | 40.00 | 5,909 | 236,360 | 21,688 | 27.6 K to 21.7 K (-21.41 %) |
Feb 19 2019 | ATRA | Atara Biotherapeut ... | Porter Derrell | SVP, Head of Global ... | Buy | M | 14.30 | 4,000 | 57,200 | 27,597 | 23.6 K to 27.6 K (+16.95 %) |